ESMSX | VEURX | ESMSX / VEURX | |
Total Expense Ratio | 1.12 | 0.24 | 467% |
Annual Report Gross Expense Ratio | 1.12 | 0.24 | 467% |
Fund Existence | 8 years | 35 years | - |
Gain YTD | 24.964 | 23.994 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 191M | 32.9B | 1% |
Annual Yield % from dividends | 4.49 | 2.88 | 156% |
Returns for 1 year | 14.24 | 15.41 | 92% |
Returns for 3 years | 31.20 | 41.79 | 75% |
Returns for 5 years | 52.88 | 46.69 | 113% |
Returns for 10 years | N/A | 49.26 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXH | 106.17 | 1.17 | +1.11% |
First Trust Health Care AlphaDEX® ETF | |||
PSR | 90.66 | 0.52 | +0.57% |
Invesco Active US Real Estate | |||
USRD | 32.87 | N/A | N/A |
Themes US R&D Champions ETF | |||
BMAR | 50.40 | -0.04 | -0.09% |
Innovator U.S. Equity Buffer ETF™ - Mar | |||
VGT | 700.05 | -4.42 | -0.63% |
Vanguard Information Technology ETF |